Marino Garcia

Insider Reports History

Location
New York, NY
Signature
/s/ Adam Veness, as attorney-in-fact for Marino Garcia
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Marino Garcia:

Company Role Class Num Shares Value Price $ Report Date Ownership
Dianthus Therapeutics, Inc. /DE/ CEO AND PRESIDENT, Director Stock Option (Right to Buy) 355,000 03 Feb 2026 Direct

Insider Reports Filed by Marino Garcia

Symbol Company Period Transactions Value $ Form Type Role Filing Time
DNTH Dianthus Therapeutics, Inc. /DE/ 03 Feb 2026 1 $0 4 CEO AND PRESIDENT, Director 04 Feb 2026, 17:39
DNTH Dianthus Therapeutics, Inc. /DE/ 30 Sep 2025 1 $0 4 CEO AND PRESIDENT, Director 03 Oct 2025, 19:00
DNTH Dianthus Therapeutics, Inc. /DE/ 03 Feb 2025 1 $0 4 CEO AND PRESIDENT, Director 04 Feb 2025, 16:13
DNTH Dianthus Therapeutics, Inc. /DE/ 23 May 2024 1 $0 4 CEO AND PRESIDENT, Director 28 May 2024, 20:03
DNTH Dianthus Therapeutics, Inc. /DE/ 24 Jan 2024 1 $0 4 CEO AND PRESIDENT, Director 26 Jan 2024, 16:36
DNTH Dianthus Therapeutics, Inc. /DE/ 11 Sep 2023 0 $0 3 CEO and President, Director 13 Sep 2023, 20:51